[Form 4] Cardinal Health, Inc. Insider Trading Activity
Cardinal Health Chief Financial Officer Aaron E. Alt reported a change in beneficial ownership on 08/12/2025. The Form 4 shows an acquisition of 67,448 common shares through performance share units that are stated to settle on August 15, 2025, with a reported transaction price of $0 (reflecting award settlement). Following the reported transaction, the filing lists total beneficial ownership of 102,396 shares. The filing was executed by an attorney-in-fact and contains an explanatory remark that the shares reflect performance share units.
Il direttore finanziario di Cardinal Health, Aaron E. Alt, ha segnalato una variazione nella propriet脿 effettiva il 08/12/2025. Il Form 4 indica l'acquisizione di 67,448 azioni ordinarie tramite unit脿 azionarie legate alla performance, con regolamento previsto il August 15, 2025, e un prezzo di transazione dichiarato di $0 (a indicare il regolamento di un premio). Dopo l'operazione, la dichiarazione riporta una partecipazione totale di 102,396 azioni. La pratica 猫 stata firmata da un procuratore e include la precisazione che si tratta di unit脿 azionarie basate sulla performance.
El director financiero de Cardinal Health, Aaron E. Alt, inform贸 un cambio en la titularidad beneficiaria el 08/12/2025. El Formulario 4 muestra la adquisici贸n de 67,448 acciones ordinarias mediante unidades de acciones por desempe帽o que se indican con liquidaci贸n el August 15, 2025, con un precio de transacci贸n declarado de $0 (reflejo de la liquidaci贸n del premio). Tras la operaci贸n registrada, la presentaci贸n enumera una titularidad beneficiaria total de 102,396 acciones. La presentaci贸n fue firmada por un apoderado y contiene la aclaraci贸n de que las acciones corresponden a unidades accionarias por desempe帽o.
Cardinal Health鞚� 斓滉碃鞛毂呾瀯鞛� Aaron E. Alt電� 08/12/2025鞐� 靾橃澋鞝� 靻岇湢甓岇潣 氤�霃欖潉 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 靹标臣欤检嫕 雼渼毳� 韱淀暣 67,448 氤错喌欤茧ゼ 旆摑頄堨溂氅�, 頃措嫻 雼渼電� August 15, 2025鞐� 瓴办牅霅� 鞓堨爼鞚搓碃 氤搓碃霅� 瓯半灅 臧�瓴╈潃 $0搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟(靸侁笀 鞝曥偘鞚� 氚橃榿). 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 齑� 靾橃澋鞝� 靻岇湢甓岇澊 102,396欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊姅 雽�毽澑鞚� 鞁ろ枆頄堨溂氅� 頃措嫻 欤检嫕鞚� 靹标臣欤检嫕 雼渼毳� 氚橃榿頃滊嫟電� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le directeur financier de Cardinal Health, Aaron E. Alt, a d茅clar茅 une modification de la propri茅t茅 b茅n茅ficiaire le 08/12/2025. Le formulaire 4 indique l'acquisition de 67,448 actions ordinaires par le biais d'unit茅s d'actions conditionn茅es 脿 la performance, dont le r猫glement est pr茅vu le August 15, 2025, avec un prix de transaction d茅clar茅 de $0 (refl茅tant le r猫glement de la prime). Apr猫s l'op茅ration signal茅e, le dossier fait 茅tat d'une propri茅t茅 b茅n茅ficiaire totale de 102,396 actions. Le d茅p么t a 茅t茅 sign茅 par un mandataire et pr茅cise que les actions correspondent 脿 des unit茅s d'actions li茅es 脿 la performance.
Der Chief Financial Officer von Cardinal Health, Aaron E. Alt, meldete am 08/12/2025 eine 脛nderung der wirtschaftlichen Eigentumsverh盲ltnisse. Das Formular 4 weist den Erwerb von 67,448 Stammaktien durch Performance-Aktieneinheiten aus, die zur Abwicklung am August 15, 2025 vorgesehen sind, und einen gemeldeten Transaktionspreis von $0 (als Hinweis auf die Ausgleichszahlung des Awards). Nach der gemeldeten Transaktion gibt die Einreichung eine Gesamtsumme von 102,396 gehaltenen Aktien an. Die Einreichung wurde von einem Bevollm盲chtigten unterzeichnet und enth盲lt den Hinweis, dass es sich um Performance-Aktieneinheiten handelt.
- Acquisition disclosed: Reporting person acquired 67,448 common shares via performance share units.
- Increased ownership: Beneficial ownership rose to 102,396 shares following the reported transaction.
- None.
Insights
TL;DR: A routine equity award settlement increased the CFO's beneficial stake by 67,448 shares to 102,396; no cash purchase was reported.
The Form 4 discloses an 08/12/2025 acquisition of 67,448 common shares credited as performance share units that will settle on August 15, 2025. The transaction price is listed as $0, consistent with issuance/settlement of awards rather than an open-market purchase. The filing increases the reported beneficial ownership to 102,396 shares. This is a disclosure of insider compensation settlement and does not include additional transactional details beyond the award settlement described in the remarks.
TL;DR: Form 4 properly reports a compensation-related issuance; filed by one reporting person and signed by an attorney-in-fact.
The document identifies the reporting person as Aaron E. Alt with the relationship noted as an officer (Chief Financial Officer). The Form indicates it was filed by a single reporting person and shows a signature by an attorney-in-fact dated 08/12/2025. The explanation clarifies the nature of the shares as performance share units scheduled to settle on August 15, 2025, which is consistent with routine executive award reporting under Section 16.
Il direttore finanziario di Cardinal Health, Aaron E. Alt, ha segnalato una variazione nella propriet脿 effettiva il 08/12/2025. Il Form 4 indica l'acquisizione di 67,448 azioni ordinarie tramite unit脿 azionarie legate alla performance, con regolamento previsto il August 15, 2025, e un prezzo di transazione dichiarato di $0 (a indicare il regolamento di un premio). Dopo l'operazione, la dichiarazione riporta una partecipazione totale di 102,396 azioni. La pratica 猫 stata firmata da un procuratore e include la precisazione che si tratta di unit脿 azionarie basate sulla performance.
El director financiero de Cardinal Health, Aaron E. Alt, inform贸 un cambio en la titularidad beneficiaria el 08/12/2025. El Formulario 4 muestra la adquisici贸n de 67,448 acciones ordinarias mediante unidades de acciones por desempe帽o que se indican con liquidaci贸n el August 15, 2025, con un precio de transacci贸n declarado de $0 (reflejo de la liquidaci贸n del premio). Tras la operaci贸n registrada, la presentaci贸n enumera una titularidad beneficiaria total de 102,396 acciones. La presentaci贸n fue firmada por un apoderado y contiene la aclaraci贸n de que las acciones corresponden a unidades accionarias por desempe帽o.
Cardinal Health鞚� 斓滉碃鞛毂呾瀯鞛� Aaron E. Alt電� 08/12/2025鞐� 靾橃澋鞝� 靻岇湢甓岇潣 氤�霃欖潉 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 靹标臣欤检嫕 雼渼毳� 韱淀暣 67,448 氤错喌欤茧ゼ 旆摑頄堨溂氅�, 頃措嫻 雼渼電� August 15, 2025鞐� 瓴办牅霅� 鞓堨爼鞚搓碃 氤搓碃霅� 瓯半灅 臧�瓴╈潃 $0搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟(靸侁笀 鞝曥偘鞚� 氚橃榿). 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 齑� 靾橃澋鞝� 靻岇湢甓岇澊 102,396欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊姅 雽�毽澑鞚� 鞁ろ枆頄堨溂氅� 頃措嫻 欤检嫕鞚� 靹标臣欤检嫕 雼渼毳� 氚橃榿頃滊嫟電� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le directeur financier de Cardinal Health, Aaron E. Alt, a d茅clar茅 une modification de la propri茅t茅 b茅n茅ficiaire le 08/12/2025. Le formulaire 4 indique l'acquisition de 67,448 actions ordinaires par le biais d'unit茅s d'actions conditionn茅es 脿 la performance, dont le r猫glement est pr茅vu le August 15, 2025, avec un prix de transaction d茅clar茅 de $0 (refl茅tant le r猫glement de la prime). Apr猫s l'op茅ration signal茅e, le dossier fait 茅tat d'une propri茅t茅 b茅n茅ficiaire totale de 102,396 actions. Le d茅p么t a 茅t茅 sign茅 par un mandataire et pr茅cise que les actions correspondent 脿 des unit茅s d'actions li茅es 脿 la performance.
Der Chief Financial Officer von Cardinal Health, Aaron E. Alt, meldete am 08/12/2025 eine 脛nderung der wirtschaftlichen Eigentumsverh盲ltnisse. Das Formular 4 weist den Erwerb von 67,448 Stammaktien durch Performance-Aktieneinheiten aus, die zur Abwicklung am August 15, 2025 vorgesehen sind, und einen gemeldeten Transaktionspreis von $0 (als Hinweis auf die Ausgleichszahlung des Awards). Nach der gemeldeten Transaktion gibt die Einreichung eine Gesamtsumme von 102,396 gehaltenen Aktien an. Die Einreichung wurde von einem Bevollm盲chtigten unterzeichnet und enth盲lt den Hinweis, dass es sich um Performance-Aktieneinheiten handelt.
FAQ
What did Cardinal Health (CAH) disclose on the Form 4?
Were any cash purchases reported in the CAH Form 4?
What is the reporting person鈥檚 role at Cardinal Health in this filing?
When will the performance share units settle according to the Form 4?
Who signed the Form 4 filing for Aaron E. Alt?
